NEWER AGENTS IN THE TREATMENT OF LEUKEMIA

[1] ISOLATION AND CHARACTERIZATION OF AZASERINE [J]. NATURE, 1954, 173 (4393) : 72 - 73

[2] BERNARD J, 1953, SEM HOP PARIS, V67, P3430

[3] EVALUATION OF CB-1348 IN HODGKINS DISEASE AND ALLIED DISORDERS [J]. ARCHIVES OF INTERNAL MEDICINE, 1956, 97 (06) : 703 - 714

[4] BUCHANAN JM, 1956, H FORD HOSPITAL INT

[5] BURCHENAL J, UNPUBLISHED

[6] BURCHENAL JH, 1949, CANCER, V2, P113, DOI 10.1002/1097-0142(194901)2:1<113::AID-CNCR2820020110>3.0.CO

[7] 2-E

[8] CLINICAL EVALUATION OF A NEW ANTIMETABOLITE, 6-MERCAPTOPURINE, IN THE TREATMENT OF LEUKEMIA AND ALLIED DISEASES [J]. BLOOD, 1953, 8 (11) : 965 - 999

[9] BURCHENAL JH, 1954, PROC AM A CANCER RES, V1, P7

[10] CLARKE DA, 1956, 129TH P M AM CHEM SO

[1] ISOLATION AND CHARACTERIZATION OF AZASERINE [J]. NATURE, 1954, 173 (4393) : 72 - 73

[2] BERNARD J, 1953, SEM HOP PARIS, V67, P3430

[3] EVALUATION OF CB-1348 IN HODGKINS DISEASE AND ALLIED DISORDERS [J]. ARCHIVES OF INTERNAL MEDICINE, 1956, 97 (06) : 703 - 714

[4] BUCHANAN JM, 1956, H FORD HOSPITAL INT

[5] BURCHENAL J, UNPUBLISHED

[6] BURCHENAL JH, 1949, CANCER, V2, P113, DOI 10.1002/1097-0142(194901)2:1<113::AID-CNCR2820020110>3.0.CO

[7] 2-E

[8] CLINICAL EVALUATION OF A NEW ANTIMETABOLITE, 6-MERCAPTOPURINE, IN THE TREATMENT OF LEUKEMIA AND ALLIED DISEASES [J]. BLOOD, 1953, 8 (11) : 965 - 999

[9] BURCHENAL JH, 1954, PROC AM A CANCER RES, V1, P7

[10] CLARKE DA, 1956, 129TH P M AM CHEM SO